These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19375272)

  • 1. [Inefficacy of vitamin K antagonists in an human immunodeficiency virus seropositive patient taking nevirapine].
    Griffon C; Gaertner S; Mirea C; Welsch M; Stephan D
    Presse Med; 2009 Nov; 38(11):1696-8. PubMed ID: 19375272
    [No Abstract]   [Full Text] [Related]  

  • 2. Single-center determination of reference factor II and factor X activity level values for the monitoring of vitamin K antagonist therapy.
    Désage S; Jousselme E; Négrier C; Nougier C; Le Quellec S; Jourdy Y
    Int J Lab Hematol; 2019 Oct; 41(5):e121-e123. PubMed ID: 31012536
    [No Abstract]   [Full Text] [Related]  

  • 3. [Protocol for adapting treatment with vitamin K antagonists before dental extraction].
    Garcia-Darennes F; Darennes J; Freidel M; Breton P
    Rev Stomatol Chir Maxillofac; 2003 Apr; 104(2):69-72. PubMed ID: 12750622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors associated with a thrombotic or bleeding event in patients treated with vitamin K antagonists.
    Béné J; Dubart AE; Senis C; Auffret M; Caron J; Gautier S
    J Mal Vasc; 2014 Jul; 39(4):248-55. PubMed ID: 24889788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conditions of resistance to vitamin K antagonists].
    Marchal G; Samama M; Charon P
    Sem Ther; 1964 Dec; 40(10):623-7. PubMed ID: 5878936
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of diseases on response to vitamin K antagonists.
    Self TH; Owens RE; Sakaan SA; Wallace JL; Sands CW; Howard-Thompson A
    Curr Med Res Opin; 2016; 32(4):613-20. PubMed ID: 26695107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antivitamin K. Introduction].
    Larcan A
    Angeiologie; 1967; 19(5):33-5. PubMed ID: 5621970
    [No Abstract]   [Full Text] [Related]  

  • 8. [Warfarin switch from fluindione in elderly patients].
    Peyro Saint Paul L; Martin J; Moslemi I; Le Hello C; Le Querrec A
    Presse Med; 2014 Feb; 43(2):221-3. PubMed ID: 24184283
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study of the efficacy of a low dose of antivitamin K and a preventive dose of low molecular weight heparin in the prevention of relapses of deep venous thrombosis after curative treatment in the aged subject].
    Pistorius MA; Said L; Planchon B
    J Mal Vasc; 1994; 19(1):68. PubMed ID: 8027686
    [No Abstract]   [Full Text] [Related]  

  • 10. [Advice for patients taking oral anticoagulants (coumadin or Previscan)].
    Rev Prat; 2007 Apr; 57(7):768. PubMed ID: 17626322
    [No Abstract]   [Full Text] [Related]  

  • 11. Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry.
    Le Heuzey JY; Ammentorp B; Darius H; De Caterina R; Schilling RJ; Schmitt J; Zamorano JL; Kirchhof P
    Thromb Haemost; 2014 May; 111(5):833-41. PubMed ID: 24651882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bleedings during vitamin K antagonist therapy associated with ciclosporin and rifampicin].
    Chouchana L; Languille E; Weiss N; Billaud EM; Lillo-Le Louet A
    Presse Med; 2013 May; 42(5):908-11. PubMed ID: 23069229
    [No Abstract]   [Full Text] [Related]  

  • 13. Prothrombotic risk of vitamin K antagonists during the first days of treatment: One more reason to use new oral anticoagulants.
    Gaertner S; Cordeanu EM; Mirea C; Stephan D
    Int J Cardiol; 2015; 186():141-2. PubMed ID: 25818758
    [No Abstract]   [Full Text] [Related]  

  • 14. Change in International Normalized Ratio Among Patients Treated With Dicloxacillin and Vitamin K Antagonists.
    Pottegård A; Henriksen DP; Madsen KG; Hellfritzsch M; Damkier P; Stage TB
    JAMA; 2015 Jul; 314(3):296-7. PubMed ID: 26197191
    [No Abstract]   [Full Text] [Related]  

  • 15. [Severe overdose in vitamin K antagonist secondary to grapefruit juice absorption].
    Desmard M; Hellmann R; Plantefève G; Mentec H
    Ann Fr Anesth Reanim; 2009 Oct; 28(10):897-9. PubMed ID: 19766437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Body Weight on Dose of Vitamin K Antagonists.
    Self TH; Wallace JL; Sakaan S; Sands CW
    South Med J; 2015 Oct; 108(10):637-43. PubMed ID: 26437201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dronedarone and vitamin K antagonists: a review of drug-drug interactions.
    Shirolkar SC; Fiuzat M; Becker RC
    Am Heart J; 2010 Oct; 160(4):577-82. PubMed ID: 20934550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug interactions with vitamin K antagonists].
    Thebault J; Tillement JP; Blatrix C
    Pathol Biol (Paris); 1973 Jun; 21(6):639-46. PubMed ID: 4581196
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biologic control of long-term anti-coagulating therapy with antivitamins K].
    Samama M; Casubolo L
    Angeiologie; 1967; 19(5):37-43. PubMed ID: 5621971
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticoagulation with anisindione in patients who are intolerant of warfarin.
    Grosset AB; Allen JE; Rodgers GM
    Am J Hematol; 1994 Jun; 46(2):138-40. PubMed ID: 8172181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.